In the past five years, the School has been intentional about creating an environment that rewards risk-taking and supports failures. It’s led to story slams and accelerators and a shift to an innovation-centric mindset.
A coordinated campus testing plan for COVID-19 that relies on saliva-based tests had its soft launch in early December. The large-scale COVID-19 screening program known as Project Quaker will allow COVID-19 to be tracked and mitigated at Penn and is an essential component for plans to bring students back to campus safely for the spring semester.
As opioid overdoses continue to grab headlines, more states are providing their communities with easier access to naloxone, which can prevent death by reversing opioid overdoses. But while naloxone may be available at township buildings, libraries, or other community locations, little is known about how schools maintain a supply and use naloxone to prepare for treating overdose.
More than 90 percent of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine. Yet, vaccine use in the United States falls short of public health goals.
On November 18, 2020, Xi Chapter welcomed undergraduate, graduate, and community inductees in our Chapter.
Type 1 diabetes (T1D) is the third most common pediatric chronic disease in the United States, and the risk of the disease has risen sharply in non-Hispanic Black (NHB) children in the last 20 years, data show. Ironically, the significant advances in T1D therapeutics over recent years, especially new technologies, may have exacerbated racial disparities in diabetes treatment and outcomes.